TickerFacts.

Natera, Inc. (NTRA): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.71B
As of 2025-12-31
$1.82B
As of 2026-06-30
+34.4%
3-year compound annual growth
+28.6%
5-year compound annual growth
2013-12-31: -$171.51M2014-12-31: -$171.34M2015-12-31: $184.76M2016-12-31: $143.58M2017-12-31: $25.42M2018-12-31: $32.16M2019-12-31: $278.71M2020-12-31: $486.24M2021-12-31: $653.30M2022-12-31: $705.74M2023-12-31: $765.33M2024-12-31: $1.20B2025-12-31: $1.71B$1.71B
2013-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$1.71B+43.2%2026-02-27, Balance as of period end
2024-12-31$1.20B+56.2%2026-02-27, Balance as of period end
2023-12-31$765.33M+8.4%2026-02-27, Balance as of period end
2022-12-31$705.74M+8.0%2025-02-28, Balance as of period end
2021-12-31$653.30M+34.4%2024-02-29, Balance as of period end
2020-12-31$486.24M+74.5%2023-03-01, Balance as of period end
2019-12-31$278.71M+766.6%2022-02-25, Balance as of period end
2018-12-31$32.16M+26.5%2021-02-26, Balance as of period end
2017-12-31$25.42M-82.3%2020-03-02, Balance as of period end
2016-12-31$143.58Mn/c2019-03-15, Balance as of period end
2015-12-31$184.76Mn/m2018-03-15, Balance as of period end
2014-12-31-$171.34Mn/m2017-03-16, Balance as of period end
2013-12-31-$171.51Mn/a2016-03-24, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Natera, Inc. (NTRA)2025-12-31$1.71B+43.2%
RadNet, Inc. (RDNT)2025-12-31$1.36B+19.6%
Fortrea Holdings Inc. (FTRE)2025-12-31$563.50M-58.6%
Guardant Health, Inc. (GH)2025-12-31-$99.31Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$577.31Mn/m
Veracyte, Inc. (VCYT)2025-12-31$1.31B+11.4%
Quest Diagnostics Inc (DGX)2025-12-31$7.21B+5.8%
Labcorp Holdings Inc. (LH)2025-12-31$8.62B+7.0%
CareDx, Inc. (CDNA)2025-12-31$303.10M-19.9%

Compare NTRA, RDNT, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗